Abstract:Objective: To construct a eukaryotic expressive plasmid for cellular repressor of E1A-stimulated genes(CREG) driven by a cardiac specific promoter α-MHC and reported by green fluorescent protein,and then to observe its expression in mouse primary cardiomyocytes in vitro.Methods: CREG fragment was released from pcDNA3.1 myc-His/hCREG plasmid by BamH I and EcoR I digestion enzymes,and then was subcloned into pEGFP-N1 plasmid to construct pCREG-EGFP-N1 plasmid.The α-MHC promoter sequence was synthesized according to Genebank,and was attached with Ase I and Nhe I restrictive endonuclease sites at each side.The α-MHC promoter sequence was released from pUC57-α-MHC plasmid by Ase I and Nhe I digestion enzyme,and then replace cytomegalo virus(CMV) promoter of pCREG-EGFP-N1 plasmid to construct pα-MHC-EGFP-N1 plasmid.Then,the recombinant pα-MHC-CREG-EGFP-N1 plasmid was then transfected into mouse primary cardiomyocytes by liposome.The green fluorescent protein expression was observed by fluorescent microscopy and CREG expression was detected by Western blot.Results: pα-MHC-CREG-EGFP-N1 was identified by enzyme digestion and sequencing analysis.The results showed that length of the target genes which were inserted into the recombinant plasmid was correct.The strong expression of green fluorecent protein was observed by fluorecent microscopy,and the expression of CREG protein was detected by Western blot.These results confirmed that mouse primary cardiomyocytes were successfully transfected with plasmid.Conclusion: The pα-MHC-CREG-EGFP-N1 eukaryotic expressive plasmid was successfully constructed and the recombinant vector provides a powerful approach in investigating the function and regulation of CREG in cardiovascular diseases development and also in producing mouse cardiomyocyte specific hyper-expressive CREG transgenic mice.

Cloning of HRE/CMV Promoters and Determination of Hypoxia Regulatory Activities

Construction and identification of hypoxia regulatory reporter vectors

Construction and Identification of an Effective Hypoxia-Inducible Expression Vector

Study on the Function of Different Promoters in Kluyveromyces lactis by Enhanced Green Fluorescent Protein

[Cloning of Mouse Adam10 Gene Promoter and Construction and Identification of Dual Luciferase Reporter System].

Comparison of Transcriptional Activities of Eight Promoters and Application of Hr5-Ie1 Promoter to Realize the Expression of EGFP in Bombyx Mori BmN Cells

Establishment of a Cell-Based Assay to Screen Regulators of the Hypoxia-Inducible Factor-1-dependent Vascular Endothelial Growth Factor Promoter.

Molecular cloning and characterization of the promoter of mouse heme-regulated eIF2alpha kinase.

Exploitation of Hypoxia Regulatory Vectors for Gene Therapy of Renal Anemia

Construction and verification of a hypoxia-induced gene therapy vector targeting hepatocellular carcinoma

[Construction and Identification of a Plasmid with EGFP Reporter Gene for Enhancer Function Analysis].

Development of a hypoxia-responsive vector for tumor-specific gene therapy

Gene expression profiling of hypoxia and reduced ROS effects on ex vivo expanded human CD34+CD38− cells

Improvement of Human AFP Promoter Efficiency by CMV Early Enhancer

Cloning and characterization of the promoters from Saccharomyces cerevisiae

Optimization of Reporter Gene Assay: Several Factors Influencing Detection of Promoter Activity.

Construction and identification of the recombinant retroviral vector to carry out hypoxia-regulated expression of neurotrophin-3

Construction of Luciferase Reporter Gene Vectors Containing Id1 Promoter Region and Id1 Promoter Activity in HepG2 Cells

Enhancement Of Biodemulsifier Produced By Alkaliphilic Alcali-Genes Sp S-Xj-1 By Ph Optimization And Waste Edible Oil Supplementation Strategy

Cloning of SPA gene promoter and analysis of its transcriptional targeting activity

Construction and Identification of α-MHC Promoter-driven CREG Eukaryotic Expressive Plasmid